Blog

• MarketBeat Week in Review – 11/4 - 11/8

Altimmune (NASDAQ:ALT) said it has strengthened its balance sheet and is preparing to begin a global Phase 3 trial of pemvidutide in metabolic

Abeona Therapeutics (NASDAQ:ABEO) reported early commercial momentum for ZEVASKYN in the first quarter of 2026, with executives highlighting new patient treatments, expanded treatment-center

Bilfinger (ETR:GBF) confirmed its 2026 outlook after reporting a slower start to the year, with management pointing to severe winter weather and geopolitical uncertainty as factors that delayed

• Big Insider Sales at NVDA, DELL, TMUS Raise Questions—Or Do They?

Deutsche Telekom (ETR:DTE) reported what Chief Executive Tim Höttges called a “robust” start to 2026, citing broad-based growth

Humacyte (NASDAQ:HUMA) reported first-quarter 2026 Symvess sales of $0.5 million and outlined a series of commercial, clinical and cost-reduction initiatives aimed at accelerating adoption of its

Brenntag (ETR:BNR) said its first-quarter 2026 results reflected a slow start to the year followed by a sharp improvement in March as volatility tied to the crisis in the Middle East lifted pricing

• Why Wyndham Hotels Is The Industry Value Play, An Earnings Story

Atour Lifestyle (NASDAQ:ATAT) reported sharply higher first-quarter revenue for 2026, driven by continued expansion of its hotel

RWE Aktiengesellschaft (ETR:RWE) reported a stronger first quarter for fiscal 2026, with Chief Financial Officer Michael Müller telling analysts that the company had a “good start” to the year and

MLP (ETR:MLP) reported record first-quarter revenue and earnings for 2026, with Chief Financial Officer Reinhard Loose saying the financial services group remained on its medium-term growth path

• Cabot Boosting Production In Lithium Battery Chain For EV Market

Orion (NYSE:OEC) raised its full-year earnings outlook after reporting first-quarter adjusted EBITDA that exceeded internal

• Bridget’s Buys: The Bottom 5 Stocks and What to Do Next

Oklo (NYSE:OKLO) reported a wider first-quarter 2026 loss as the advanced nuclear developer said it is moving further into asset deployment

• MarketBeat Week in Review – 02/09 - 02/13

Once Upon A Farm (NYSE:OFRM) raised its full-year revenue outlook after reporting first-quarter fiscal 2026 sales growth of nearly 44%, driven by higher

Deutsche Börse (ETR:DB1) used its annual general meeting to highlight another record year, outline its “Leading the Transformation” strategy and address shareholder questions on capital returns

• 3 High-Potential Stocks Analysts Say Could Soar

Owens Corning (NYSE:OC) reported lower first-quarter revenue as weaker residential construction and repair-and-remodel demand continued to pressure

Conduit (LON:CRE) reported higher first-quarter gross written premiums and said it continues to find selective growth opportunities, even as reinsurance market competition increases and pricing

Blue Owl Capital (NYSE:OBDC) reported first-quarter 2026 adjusted net investment income of $0.31 per share and net asset value per share of $14.41, as management said lower base rates, tighter

• How Berkshire Hathaway Performed During Buffett's Final Quarter

New York Times (NYSE:NYT) reported a strong start to 2026, with executives pointing to continued digital subscription growth, a sharp

• On Holdings Sets Up for Marathon Rally: New Highs Are Coming

Realty Income (NYSE:O) raised its full-year outlook after reporting higher first-quarter adjusted funds from operations and detailing a

• 3 Bargain Stocks Under $20 With Major Growth Potential

NexGen Energy (NYSE:NXE) said its first quarter of 2026 marked a major transition point for the company, with Chief Executive Officer and

• 5 Dividend Kings Stocks to Load Up on Now

Northwest Natural Gas (NYSE:NWN) said first-quarter 2026 results were strong and in line with management’s expectations, driven by new rates, customer

• Beverage Stocks for a Refreshing 2020

Heidelberg Materials (ETR:HEI) used its 137th annual general meeting to highlight record 2025 results, a higher proposed dividend, continued share buybacks and

Avon Protection (LON:AVON) reported a strong first half, with executives saying revenue, profit and returns improved materially as the group’s multi-year transformation program nears completion and

Hapag-Lloyd Aktiengesellschaft (ETR:HLAG) reported a weaker first quarter of 2026, with management describing the start to the year as “unsatisfactory” as severe weather, weak Atlantic trade and

JOST Werke (ETR:JST) reported a record first quarter for 2026, with management citing strong organic growth, early benefits from the Hyva integration and improving profitability despite mixed

Caris Life Sciences (NASDAQ:CAI) executives said the company is expanding its commercial reach, product pipeline and biopharma partnerships as it looks to build on recent revenue growth following